Episode Details
Back to Episodes
Pharmaceutical Executive Daily: Mike Doustdar Open to Direct Listing for Novo Shares
Published 1 month, 3 weeks ago
Description
EVERSANA's Jen Norton talks about how AI is reshaping market access strategy, a new analysis from MIT and Harvard Business School names clinical data harmonization as the real barrier to enterprise AI adoption in life sciences, and Novo Nordisk's CEO says he's open to a direct NYSE listing.